CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Increasing adoption of companion animals
4.1.2. Growth in livestock population and repeated outbreaks of livestock diseases
4.1.3. Initiatives by various government agencies, animal associations, and key players
4.1.4. Increasing incidences of zoonotic diseases
4.1.5. The innovation of new types of vaccines
4.2. Market Restraints & Challenges
4.2.1. Inadequate surveillance and reporting systems
4.2.2. High storage costs for vaccines
4.3. Market Opportunities
4.3.1. Growing awareness of animal health in emerging economies
4.3.2. Technological advancements
CHAPTER 5. GLOBAL ANIMAL VACCINES MARKET – BY TYPE
5.1. Poultry vaccines
5.2. Porcine vaccines
5.3. Livestock vaccines
5.3.1. Bovine vaccines
5.3.2. Small Ruminant vaccines
5.4. Companion Animal vaccines
5.4.1. Canine vaccines
5.4.2. Feline vaccines
5.5. Aquaculture vaccines
5.6. Other Animal vaccines
CHAPTER 6. GLOBAL ANIMAL VACCINES MARKET – BY DISEASE
6.1. Porcine Parvovirus
6.2. Swine Pneumonia
6.3. Avian Influenza
6.4. Rabies
6.5. Clostridial Diseases
6.6. Others
CHAPTER 7. GLOBAL ANIMAL VACCINES MARKET – BY TECHNOLOGY
7.1. Live attenuated vaccines
7.2. Toxoid vaccines
7.3. Inactivated vaccines
7.4. Recombinant vaccines
7.5. Other vaccines
CHAPTER 8. GLOBAL ANIMAL VACCINES MARKET - BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.2.4. Costa Rica
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Chile
8.3.4. Columbia
8.3.5. Others
8.4. Europe
8.4.1. U.K.
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Netherlands
8.4.8. Switzerland
8.4.9. Poland
8.4.10. Others
8.5. APAC
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Australia & New Zealand
8.5.6. Malaysia
8.5.7. Singapore
8.5.8. Others
8.6. Middle East & Africa
8.6.1. UAE
8.6.2. Saudi Arabia
8.6.3. Iran
8.6.4. Iraq
8.6.5. Qatar
8.6.6. South Africa
8.6.7. Algeria
8.6.8. Morocco
8.6.9. Nigeria
8.6.10. Egypt
8.6.11. Others
CHAPTER 9. GLOBAL ANIMAL VACCINES MARKET - COMPANY PROFILES
9.1. Jinyu Bio-Technology Group Co., Ltd
9.2. China Animal Husbandry Group
9.3. Tianjin Ringpu Biotechnology Co., Ltd
9.4. Biogenesis Bago S.A.
9.5. IDT Biologika GmbH
9.6. Hipra S.A.
9.7. Hester Biosciences Limited
9.8. Phibro Animal Health
9.9. Vetoquinol S.A.
9.10. Virbac Group
9.11. Ceva Sante Animale
9.12. Elanco Animal Health
9.13. Boehringer Ingelheim GmbH
9.14. Merck & Co., Inc.
9.15. Zoetis, Inc.
CHAPTER 10. GLOBAL ANIMAL VACCINES MARKET - COMPETITIVE
LANDSCAPE
10.1. Market Share Analysis
10.2. Strategies adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 11. MARKET INSIGHTS
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
CHAPTER 12. APPENDIX
12.1. List of Tables
12.2. List of Figures
